Kristen Kluska
#56 out of 1697 analysts
Cantor Fitzgerald
Automatically Tracked
Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
Gain and growth charts are calculated per selected timeframe:
134.23%
Gain -4.26%
Monthly
0.84%
Yearly
10.55%
Drawdown
37.73%
$196,008.29
Equity
Holdings
$196,008.26
Cash
$0.03
Investment
$278,363.97
$96,007.71
Profit -$8,715.75
Realized
$178,363.41
Unrealized
-$82,355.71
Dividends
$0
$0.03
Cash
Deposits
$100,000.59
Withdrawals
$0
Commissions
$0
Goals
Avg. 0% completed goals
Today
Compared To Yesterday
Gain
-4.26%
Profit
-$8,715.75
Win %
33%
This Week
Compared To Last Week
Gain
-10.55%
Profit
-$23,112.74
Win %
33%
This Month
Compared to last month
Gain
-16.51%
Profit
-$38,752.74
Win %
33%
This Year
Compared to last year
Gain
-1.3%
Profit
-$2,584.83
Win %
44%
Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 1292 | Longs Won 687/1292 53% | Profit Factor 1.23 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $2,982.23 |
| Average Win $750.87 | Best Trade (Aug 27) $77,641.23 | Sharpe Ratio -128.74 |
| Average Loss -$693.96 | Worst Trade (Oct 16) -$33,654.34 | Z-Score -10.22 (100%) |
| Commissions $0 | Avg. Trade Length 2m 2w 3d | Expectancy $74.31 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | 0.06% | 0.54% | 2% | 5.09% | 10.52% | 19.02% | 31.38% | 48.43% | 71.01% |
| Consecutive Losing Trades | 282 | 254 | 226 | 198 | 169 | 141 | 113 | 85 | 56 | 28 |
Hover over the desired column for a detailed explanation.
Returns
Overall, Monthly| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
 ABEO Abeona Therapeutics Inc. | 9,000.8 | $50,134.43 | $39,738.51 | - | -$10,395.92 | -20.74% | -5.054% |
 CAPR Capricor Therapeutics Inc. | 5,533.6 | $36,798.45 | $37,296.47 | - | $498.02 | 1.35% | -7.29% |
 CLDX Celldex Therapeutics Inc. | 1,311.05 | $50,134.43 | $36,696.2 | - | -$13,438.23 | -26.8% | -3.249% |
 RARE Ultragenyx Pharmaceutical Inc. | 3,455.16 | $84,297.58 | $50,739.08 | - | -$33,558.5 | -39.81% | -3.197% |
 SLDB Solid Biosciences Inc. | 5,626.76 | $56,999.08 | $31,537.99 | - | -$25,461.09 | -44.67% | -2.352% |
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
2026 © Marketlog. All Rights Reserved.
